Home Medivir

Medivir

In operation
Post-IPO Round
Developer of Innovative Cancer Therapies

Basic Information

Medivir is a pharmaceutical company focused on developing innovative cancer therapies. To do this efficiently and achieve a high success rate, we combine a unique and balanced mix of clinical development expertise, a collaborative culture, and extensive industry experience with a well-balanced project portfolio.
Medivir AB
Stockholm,Stockholm,Sweden
101~500 people
January 01, 1988
info@medivir.com